Streetbeat News

Regulatory

SHPH

Shuttle Pharmaceuticals Holdings, Inc. has regained compliance with Nasdaq's Minimum Bid Price Rule by maintaining a stock price above $1.00 for ten consecutive trading days.

Portfolio Pulse from Benzinga Newsdesk

August 28, 2024 | 1:02 pm

FXI

SPY

U.S. National Security Adviser Jake Sullivan and Chinese officials have discussed the importance of military-to-military communications, planning a 'theater commander telephone call' soon. This development could ease tensions and improve diplomatic relations between the U.S. and China.

Portfolio Pulse from Benzinga Newsdesk

August 28, 2024 | 12:45 pm

FXI

White House National Security Adviser and Chinese officials engaged in candid and constructive discussions on various bilateral, regional, and global issues, as reported by Reuters citing a White House statement.

Portfolio Pulse from Benzinga Newsdesk

August 28, 2024 | 12:42 pm

ATOS

Atossa Therapeutics has been granted a new patent for compositions comprising Endoxifen and an anteric material, where at least 90% of the Endoxifen is (Z)-Endoxifen. This patent could enhance Atossa's intellectual property portfolio and potentially impact its market position.

Portfolio Pulse from Benzinga Newsdesk

August 28, 2024 | 12:33 pm

ICCM

IceCure Medical Ltd. (NASDAQ:ICCM) has received a Notice of Allowance from the USPTO for a continuation patent on its 'Cryogenic Pump' technology, enhancing its global IP leadership in cryoablation technologies. This patent broadens the applications of IceCure's platform, with over 50 patents issued worldwide.

Portfolio Pulse from Benzinga Newsdesk

August 28, 2024 | 12:32 pm

AZTR

Azitra has initiated a Phase 1b clinical trial for ATR-12, targeting Netherton Syndrome. The trial will involve 12 adults over 14 days, with interim safety data expected in early 2025 and full results in the second half of 2025.

Portfolio Pulse from Benzinga Newsdesk

August 28, 2024 | 12:31 pm

WATT

Energous Corporation (NASDAQ:WATT) has received full FCC certification for its 2W PowerBridge transmitter system, marking it as the first certified transmitter at this power level. This system enhances wireless power networks by providing up to 8W EIRP, improving supply chain visibility and enabling continuous wireless power and real-time data for connected devices.

Portfolio Pulse from Benzinga Newsdesk

August 28, 2024 | 12:31 pm

ARQT

Arcutis Biotherapeutics reported positive long-term results from its INTEGUMENT-OLE study, demonstrating the efficacy and safety of Roflumilast Cream 0.05% for treating mild to moderate atopic dermatitis in children. The company plans to submit a supplemental New Drug Application (sNDA) to the FDA in Q1 2025.

Portfolio Pulse from Benzinga Newsdesk

August 28, 2024 | 12:07 pm

GMGI

Golden Matrix Group is expanding its presence in the iGaming market by applying for a license in New Jersey, obtaining a license in Bulgaria, and targeting Brazil's $20 billion market through its subsidiary, Meridianbet.

Portfolio Pulse from Benzinga Newsdesk

August 28, 2024 | 12:06 pm

BIOR

Biora Therapeutics has been granted an extension by Nasdaq to regain compliance with its listing requirements. This extension provides the company with additional time to meet the necessary criteria to remain listed on the exchange.

Portfolio Pulse from Benzinga Newsdesk

August 28, 2024 | 12:01 pm